| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |